Medical Equipment

STD Diagnostics Market Size Outlook and Demand Growth Across 2026–2030

March 17, 2026March 17, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Anticipated For The STD Diagnostics Market Over The Period 2026–2030?

The std diagnostics market has seen a rapid increase in its size over recent years. It is projected to expand from $10.77 billion in 2025 to $11.91 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.6%. The historical expansion of this market can be attributed to an increasing prevalence of sexually transmitted infections, the broader expansion of diagnostic laboratory infrastructure, the growth of public health screening programs, rising awareness regarding sexual health, and the availability of advanced nucleic acid testing.

The std diagnostics market is projected for substantial expansion in the coming years, expected to reach $17.52 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.1%. This anticipated growth is driven by the increasing demand for rapid diagnostics, a rise in the adoption of home-based testing kits, broader penetration of molecular diagnostics, growing investments in public health surveillance, and a heightened focus on confidential and accessible testing services. Key trends during this period include the increasing uptake of rapid and point-of-care STD tests, the rising use of molecular diagnostic technologies, expanding integration of automated laboratory systems, the proliferation of at-home STD testing solutions, and an enhanced emphasis on early and accurate disease detection.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8507&type=smp

What Underlying Factors Are Accelerating The Growth Of The STD Diagnostics Market?

An increasing incidence of STDs is anticipated to drive the expansion of the STD diagnostics market in the future. STDs, which stand for sexually transmitted diseases, are infections passed via sexual contact, necessitating professional medical diagnosis and care. The surge in STDs is fueled by heightened sexual activity and evolving social norms among younger demographics; decreased stigma concerning sexual health and enhanced mobility foster broader sexual networks and accelerate transmission rates. This expanding STD prevalence directly translates into a greater need for diagnostic testing services and associated products, given that healthcare professionals depend on precise laboratory tests, screening kits, and detection methods to pinpoint infections and curb further spread. As an illustration, in September 2025, data from the Centers for Disease Control and Prevention, a US-based governmental body, indicated that congenital syphilis had climbed for its twelfth consecutive year, with nearly 4,000 reported cases in 2024. Consequently, the escalating occurrence of STDs is fueling the expansion of the STD diagnostics market.

How Is The STD Diagnostics Market Divided Into Its Major Segments?

The std diagnostics market covered in this report is segmented –

1) By Type: Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus Testing, Human Papilloma Virus Testing, Human Immunodeficiency Virus Testing, Chancroid Testing

2) By Location Of Testing: Laboratory Testing, Point Of Care (PoC) Testing

3) By End-User: Hospitals And Clinics, Diagnostic Centers, Homecare

Subsegments:

1) By Chlamydia Testing: Nucleic Acid Amplification Tests (NAAT), Antigen Tests

2) By Syphilis Testing: Rapid Plasma Reagin (RPR) Tests, Treponemal Tests

3) By Gonorrhea Testing: Nucleic Acid Amplification Tests (NAAT), Culture Tests

4) By Herpes Simplex Virus Testing: PCR Tests, Serological Tests

5) By Human Papilloma Virus Testing: HPV DNA Tests, HPV RNA Tests

6) By Human Immunodeficiency Virus Testing: Antibody Tests, Antigen Or Antibody Tests, Nucleic Acid Tests (NAT)

7) By Chancroid Testing: Culture Tests, Nucleic Acid Tests

How Are Trends Transforming The STD Diagnostics Market Landscape?

Leading companies in the STD diagnostics market are dedicated to developing innovative solutions, such as real-time PCR kits, to meet evolving medical needs and enhance diagnostic capabilities. A real-time PCR kit encompasses a collection of reagents necessary for performing real-time polymerase chain reaction (qPCR), a highly sensitive and extensively utilized method for identifying and quantifying specific nucleic acid sequences. For example, in March 2023, Jiangsu Bioperfectus Technologies Co. Ltd., a research and development company situated in China, released the Mycoplasma Hominis Real Time PCR Kit and the Treponema Pallidum Real Time PCR Kit, specifically engineered for the detection of Mycoplasma hominis and Treponema pallidum. These products additionally boast high sensitivity and specificity, ease of operation, a swift turnaround time, and the capability to identify multiple pathogens in a single test.

Who Are The Prominent Organizations Shaping The STD Diagnostics Market?

Major companies operating in the std diagnostics market are Abbott Laboratories, Qiagen Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Hologic Inc., Bio-Rad Laboratories Inc., Becton Dickinson and Company, Thermo Fisher Scientific Inc., Biocartis NV, Trinity Biotech PLC, Binx Health Inc., NOWDiagnostics Inc., Atlas Genetics Ltd., BioFire Diagnostics LLC, BioMérieux SA, Chembio Diagnostic Systems Inc., Corgenix Medical Corporation, Creative Diagnostics, Curetis AG, Daktari Diagnostics, Enzo Biochem Inc., Fujirebio Diagnostics Inc., GenePOC Inc., GenMark Diagnostics Inc., Grifols Diagnostic Solutions Inc., Hain Lifescience GmbH, Luminex Corporation, Meridian Bioscience Inc., Mesa Biotech Inc., Mobidiag Oy

Read the full std diagnostics market report here:

https://www.thebusinessresearchcompany.com/report/std-diagnostics-global-market-report

Which Region Is Projected To Dominate The STD Diagnostics Market During The Forecast Period?

North America was the largest region in the STD diagnostics market share in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the std diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored STD Diagnostics Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=8507&type=smp

Browse Through More Reports Similar to the Global STD Diagnostics Market 2026, By The Business Research Company

Sexually Transmitted Infections Stis Market Report 2026

https://www.thebusinessresearchcompany.com/report/sexually-transmitted-infections-stis-global-market-report

Womens Health Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/womens-health-diagnostics-global-market-report

Companion Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/companion-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795